Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) (NCT06907173)

🧪 Interventions in This Study

• Levetiracetam (LEV) (60 mg/Kg) + 1 mg/kg Ketamine (KET) (DRUG)
• Levetiracetam (LEV) (60 mg/Kg) + 3 mg/kg Ketamine (KET) (DRUG)
• Levetiracetam (LEV) (60 mg/Kg) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (52 Sites)

Showing the first 25 of 52 sites.

• Banner University Medical Center - Tucson Campus — Tucson, Arizona
• Ronald Reagan UCLA Medical Center — Los Angeles, California
• Children's Hospital Los Angeles — Los Angeles, California
• Stanford University Medical Center — Palo Alto, California
• UC Davis Medical Center — Sacramento, California
• San Francisco General Hospital — San Francisco, California
• UCSF Medical Center — San Francisco, California
• Yale New Haven Hospital — New Haven, Connecticut
• Christiana Hospital — Newark, Delaware
• Nemours Children's Hospital — Wilmington, Delaware
• Children's National Medical Center — Washington D.C., District of Columbia
• Orlando Regional Medical Center — Orlando, Florida
• Grady Memorial Hospital — Atlanta, Georgia
• Arthur M. Blank Hospital — Atlanta, Georgia
• Northwestern Memorial Hospital — Chicago, Illinois
• Comer Children's Hospital — Chicago, Illinois
• University of Chicago Medical Center — Chicago, Illinois
• IU Health Methodist Hospital — Indianapolis, Indiana
• Riley Hospital for Children — Indianapolis, Indiana
• University of Iowa Medical Center — Iowa City, Iowa
• University of Maryland Medical Center — Baltimore, Maryland
• Massachusetts General Hospital — Boston, Massachusetts
• University of Michigan University Hospital — Ann Arbor, Michigan
• Detroit Receiving Hospital — Detroit, Michigan
• Sinai-Grace Hospital — Detroit, Michigan

📞 Contact the Study Coordinator

Phone: (434) 243-6768

Email: mew5j@virginia.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Status Epilepticus

• The STatus Epilepticus Prognosis Study — London, Ontario
• Rapid-Response EEG in Children With Suspected Status Epilepticus — The Bronx, New York
• Improving Status Epilepticus Treatment Times — Columbus, Ohio

Explore by condition: All Status Epilepticus clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.